Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiyuancong for Sudden Sensorineural Hearing Loss
NCT07505667Recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Nov 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Yiyuancong in sudden sensorineural hearing loss (SSHL) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Change in Pure-Tone Audiometry Hearing Threshold at Month 2. Started Nov 2025; status: recruiting.
02
Drugs
Yiyuancong
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT07505667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07505667.